Home Search

bladder cancer - search results

If you're not happy with the results, please do another search
Illustration of the prostate organ in blue surrounded by red cancer cells to symbolize prostate cancer

FOXA1’s Prostate Tumor-Driving Mechanisms Revealed

Researchers have uncovered three ways FOXA1 (Forkhead box A1) gene mutations override normal biology to drive an estimated one-third of prostate cancers. Dubbed FAST,...

BGI Genomics to Commercialize Natera’s Signatera Assay in China

Signatera’s methodology differs from current liquid biopsy tests, which test for a fixed panel of therapeutically relevant genes
Conceptual image for viral ethiology of prostate cancer

Bio-Techne to Acquire Exosome Diagnostics for Up to $575M

The deal will position Bio-Techne as a leader in non-invasive liquid biopsies and diagnostics for CAR-T cancer therapies
After fewer Rosetta shareholders approved the deal than needed for completion

Genoptix Terminates Planned $10M Acquisition of Rosetta Genomics

Companies say Genoptix interested in 'alternative options' after fewer Rosetta shareholders approve the deal than needed for completion
Finger with drop of fresh blood

DxTerity, City of Hope Collaborate on Test to Predict Efficacy of Radiation Therapy

The work is part of the RADIANT study to validate DxTerity's blood test for identifying patients likely to benefit from radiation treatment.
Woman donating blood

Biocept to Study CTC Diagnostics Platform for Immunotherapy Targets

Company taps researcher Dr. Shilp Gupta to observe performance of its technology for detecting PD-L1 and AR in bladder and prostate cancer.
Source: iStock/© claudiobaba

MDx Health Buys NovioGendix for Up to $8.8M

MDx Health plans to acquire NovioGendix for up to $8.8 million, the companies said today, in a deal that expands the buyer’s uro-oncology offerings...
Source: iStock/© AlexRaths

Rosetta Genomics to Acquire PersonalizeDx

Rosetta Genomics said today it has agreed to acquire CynoGen, which does business as PersonalizeDx, from Prelude, in a purchase that expands the buyer’s...


Inside Precision Medicine